The global eClinical solutions market size is expected to reach USD 12.05 million by 2025

LONDON, June 26, 2018 /PRNewswire/ -- eClinical Solutions Market Size, Share, & Trends Analysis Report By Product (CTMS, eCOA, EDC & CDMS), By Delivery Mode (Web-hosted, Cloud-based), By Development Phase, By End Use, And Segment Forecasts, 2018 - 2025

Download the full report: https://www.reportbuyer.com/product/5445429

The global eClinical solutions market size is expected to reach USD 12.05 million by 2025 progressing at a CAGR of 13.6% during the forecast period. Increasing research and development activities by biopharma and pharma companies, rising application of software solutions in clinical trials, and expanding customer base are anticipated to fuel the demand for eClinical solutions.

The eClinical solutions market is estimated to witness phenomenal growth over the forecast period.Technological advancements in the field of clinical trials such as electronic data capture and prevalence of Wi-Fi connectivity are projected to drive the market in coming years.

As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the growth of the market over the forecast period.

Moreover, digital transformation in the field of clinical trials and shifting preference towards data centric approach are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to massive volume of data generated during clinical development processes. eClinical solutions offer single source of information that helps in optimizing the cost by eliminating redundant data entry and reducing on-site verification and source data verification rate. Rising awareness regarding these benefits is propelling the market.

Adoption of eClinical workflows in trials offer enormous potential in clinical development processes.These solutions can facilitate decision making in each stage of development.

It also helps in reducing cost & time between development phase by utilizing seamless designs & identifying failing compounds. In addition, it offers rapid access to data & patient safety information, which is helpful in making quick decisions.

Further Key Findings From the Study Suggest:
• CTMS dominated the product segment in 2016 owing to associated benefits such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
• On-premise eClinical solutions are most commonly preferred solutions. The preference for these services is mainly due to complete access to information and have full control within the premise
• Key market players are engaged in various strategies such as mergers & acquisitions and new product development to gain market penetration
• New product development and strategic alliances including partnership agreements, promotional activities, and acquisitions are instrumental in keeping market rivalry high
• For instance, in February 2016, Oracle Health Sciences entered into an agreement with Bayer Healthcare to provide its clinical e-monitoring solutions, Oracle Siebel Clinical Trial Management System, to the latter

Download the full report: https://www.reportbuyer.com/product/5445429

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com